[Alpha Tau in GlobeNewswire] Alpha Tau appoints business veteran Peter Melnyk as Chief Business Officer

JERUSALEM, Sept. 01, 2022 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (Nasdaq: DRTS) (“Alpha Tau”), the developer of the modern alpha-radiation most cancers remedy Alpha DaRT™, introduced right now that Peter Melnyk, a member of its board of administrators, has resigned from the Firm’s Board of Administrators with a view to assume the full-time place of Alpha Tau’s Chief Business Officer.

Learn extra right here.